Latest Breaking News On - Patients with advanced cancers - Page 1 : comparemela.com

Robert Albert Anders, MD, PhD, discusses the rationale for developing CCR4 antagonists for use in patients with advanced cancers, including lymphoma and non–small cell lung cancer.

Robert albert andersDepartment of pathologyDepartment of oncologyGastrointestinal cancerLiver pathologySidney kimmel comprehensive cancer centerJohns hopkinsSidney kimmel comprehensive cancer center at johns hopkinsCcr4 antagonistsPatients with advanced cancers